ES8301630A1 - Procedimiento para obtener una preparacion farmaceutica que comprende un nucleo recubierto de polimero acrilico y poli- mero insoluble en agua. - Google Patents

Procedimiento para obtener una preparacion farmaceutica que comprende un nucleo recubierto de polimero acrilico y poli- mero insoluble en agua.

Info

Publication number
ES8301630A1
ES8301630A1 ES81502345A ES502345A ES8301630A1 ES 8301630 A1 ES8301630 A1 ES 8301630A1 ES 81502345 A ES81502345 A ES 81502345A ES 502345 A ES502345 A ES 502345A ES 8301630 A1 ES8301630 A1 ES 8301630A1
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
coating
release properties
improved release
quaternary ammonium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES81502345A
Other languages
English (en)
Spanish (es)
Other versions
ES502345A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20341009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8301630(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hassle AB filed Critical Hassle AB
Publication of ES502345A0 publication Critical patent/ES502345A0/es
Publication of ES8301630A1 publication Critical patent/ES8301630A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES81502345A 1980-05-21 1981-05-20 Procedimiento para obtener una preparacion farmaceutica que comprende un nucleo recubierto de polimero acrilico y poli- mero insoluble en agua. Expired ES8301630A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8003805A SE8003805L (sv) 1980-05-21 1980-05-21 En farmaceutisk beredning med forbettrade utlosningsegenskap

Publications (2)

Publication Number Publication Date
ES502345A0 ES502345A0 (es) 1982-12-16
ES8301630A1 true ES8301630A1 (es) 1982-12-16

Family

ID=20341009

Family Applications (1)

Application Number Title Priority Date Filing Date
ES81502345A Expired ES8301630A1 (es) 1980-05-21 1981-05-20 Procedimiento para obtener una preparacion farmaceutica que comprende un nucleo recubierto de polimero acrilico y poli- mero insoluble en agua.

Country Status (9)

Country Link
EP (1) EP0040590A3 (OSRAM)
DK (1) DK221281A (OSRAM)
ES (1) ES8301630A1 (OSRAM)
GR (1) GR75634B (OSRAM)
NO (1) NO811721L (OSRAM)
PH (1) PH16539A (OSRAM)
PT (1) PT73065B (OSRAM)
SE (1) SE8003805L (OSRAM)
ZA (1) ZA813017B (OSRAM)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
US5472710A (en) * 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
EP0386967B1 (en) * 1989-03-10 1995-07-12 Yamanouchi Pharmaceutical Co. Ltd. A drug-release controlling coating material for long acting formulations
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
GEP19971086B (en) * 1991-02-22 1997-12-02 Tillotts Pharma Ag Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
WO1992016214A1 (en) * 1991-03-15 1992-10-01 Norwich Eaton Pharmaceuticals Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE29502547U1 (de) * 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6303144B1 (en) 1998-02-10 2001-10-16 Welfide Corporation Preparations with controlled release
WO2000044353A1 (de) 1999-01-29 2000-08-03 Losan Pharma Gmbh Pharmazeutische zusammensetzungen
IT1318376B1 (it) * 2000-03-07 2003-08-25 Pharmatec Internat S R L Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
WO2003096874A2 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
PA8578501A1 (es) 2002-07-25 2005-02-04 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
DE112005000730B4 (de) 2004-03-30 2017-12-21 Relypsa, Inc. (n.d.Ges.d. Staates Delaware) Ionen bindende Polymere und ihre Verwendung
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
JP4971159B2 (ja) * 2004-08-13 2012-07-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング プラミペキソール又はその薬学的に許容しうる塩を含有する徐放性ペレット製剤、その製法及び使用
US8889184B2 (en) * 2006-09-07 2014-11-18 Losan Pharma Gmbh Particulate form of a pharmaceutical composition which is easy to swallow
EP2227225B1 (en) 2008-01-10 2018-11-14 Evonik Röhm GmbH Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release
BRPI0821985A2 (pt) * 2008-01-10 2015-06-23 Evonik Roehm Gmbh Preparacao farmacêutica ou nutracêutica revestida tendo liberação de substância ativa controlada
CA2739465C (en) 2008-10-03 2017-01-31 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
EP4057998A1 (fr) 2019-11-13 2022-09-21 Ethypharm Procédé de fabrication d'une composition pharmaceutique à administration orale et à délivrance colonique
FR3102931B1 (fr) 2019-11-13 2021-12-24 Ethypharm Sa Procédé de fabrication d’une composition pharmaceutique à administration orale et à délivrance colonique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
DE2150539A1 (de) * 1970-06-11 1973-04-19 Richardson Merrell Inc Mittel gegen den befall von pferden durch dassel-larven
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung

Also Published As

Publication number Publication date
PH16539A (en) 1983-11-10
EP0040590A3 (en) 1983-01-12
EP0040590A2 (en) 1981-11-25
GR75634B (OSRAM) 1984-08-01
NO811721L (no) 1981-11-23
DK221281A (da) 1981-11-22
ES502345A0 (es) 1982-12-16
ZA813017B (en) 1982-05-26
PT73065B (en) 1983-02-08
SE8003805L (sv) 1981-11-22
PT73065A (en) 1981-06-01

Similar Documents

Publication Publication Date Title
ES8301630A1 (es) Procedimiento para obtener una preparacion farmaceutica que comprende un nucleo recubierto de polimero acrilico y poli- mero insoluble en agua.
DZ593A1 (fr) Résinate d'un acide carboxylique substitué, procédé pour sa préparation, son utilisation et compositions pharmaceutiques le contenant.
DE3277061D1 (en) Aqueous alcoholic dispersions of ph sensitive polymers and plasticizing agents, a process for preparing the same, and a solid medicinal oral dosage form containing an enteric coating prepared by using same
DK508883A (da) Dispergerbart polymerpulver til brug ved fremstilling af overtraek til medicinalvarer og fremgangsmaade til fremstilling af et saadant pulver
DE2960292D1 (en) 17-beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes, their pharmaceutical use and processes for their preparation
JPS5443286A (en) Twoostage preparation of polymer emulsion product containing no surfaceeactive agent
FR2325663A1 (fr) Procede de preparation d'emulsions aqueuses stables de polymeres et copolymere d'addition
IL58697A0 (en) Analgesic pharmaceutical compositions in the form of effervescent powders comprising metoclopramide
DE2966564D1 (en) Therapeutic compositions with enhanced bioavailability and process for their preparation
BE822688A (fr) Ionomeres de forme spherique et copolymeres d'ethylene/acide carboxylique en poudres et leur preparation
BE847095A (fr) Comprime pour la liberation controlee d'un medicament et sa preparation,
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
ATE89571T1 (de) Haarbehandlungsharze.
AU528098B2 (en) Analgesic tablet
FR2527231B1 (fr) Bains de revetement d'alliages de zinc, renfermant des brillanteurs constitues de derives d'acide b-aminopropionique et de ses polymeres
BE837628A (fr) Procede pour la preparation d'hydrocarbures et de composes oxygenes
IL65922A (en) Preparation of apovincaminic acid esters,certain novel optically active trans-derivatives thereof and pharmaceutical compositions containing them
FR2330395A1 (fr) Ester isobutylique de l'acide 2,6-dimethyl-3-methoxycarbonyl-4-(2'nitrophenyl)-1,4-dihydropyridine-5-carboxylique, son procede de preparation et medicament a usage coronarien le contenant
FR2520230B1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
DE2962753D1 (en) Acrylyl or methacrylyl ureas containing quaternary groups and process for their preparation
ES500670A0 (es) Procedimiento de preparar farmacos con liberacion programada de materia activa.
PT78776A (fr) Procede de preparation de derives de l'acide bicyclo(3.2.1.)carboxylique et de compositions pharmaceutiques les contenant
JPS5484020A (en) Composition for coating medicine and method for coating the same
FR2505329B1 (fr) Esters 2-methoxyphenyliques d'amino-acides n-substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
PT74952B (fr) Procede de preparation de derives heterocycliques d'amidoximes et de compositions pharmaceutiques les contenant